UPDATE : Sunday, February 23, 2020
상단여백
Vivozon stops short of meeting primary endpoint for P2b trial of nonnarcotic analgesics
Vivozon said that it has obtained good clinical results from the U.S. phase...
by Lee Han-soo  |  2019-11-26 18:48
라인
Amgen releases analysis result showing benefits of LDL-C treatment
Amgen Korea said it has presented the analysis of its high cholesterol (LDL...
by Lee Han-soo  |  2019-11-26 17:05
라인
Roche’s flu treatment Xofluza wins approval
A new influenza treatment has arrived in Korea in over 20 years.The Ministr...
by Kim Yun-mi  |  2019-11-26 16:08
라인
Immunotherapies give hope for esophageal cancer patients
In curing esophageal cancer, there has been no treatment option other than ...
by Kim Yun-mi  |  2019-11-26 15:37
라인
GC Labcell hands over NK cell-treating tech to US lab
GC Labcell said it has transferred its natural killer (NK) cell treatment t...
by Lee Han-soo  |  2019-11-26 15:33
라인
SK Biopharm to speed up global advance through XCOPRI’s launch
SK Biopharmaceuticals will launch its antiepileptic drug, XCOPRI, in the se...
by Lee Han-soo  |  2019-11-26 14:16
라인
Huons Global wins KGMP certification for BTX plant
Huons Global said that the Ministry of Food and Drug Safety has granted the...
by Lee Han-soo  |  2019-11-25 16:00
라인
Gtree enrolls 200 patients for US trial of dry eye treatment
ReGenTree, the U.S. subsidiary of Gtree BNT, said that it has managed to en...
by Lee Han-soo  |  2019-11-25 14:49
라인
Daewoong renews EU GMP certification for BTX plant
Daewoong Pharmaceutical said that it has renewed its EU good manufacturing ...
by Lee Han-soo  |  2019-11-25 11:55
라인
SK Biopharm's antiepileptic drug is 1st local medicine to win FDA nod independently
SK Biopharmaceuticals' XCOPRI, a treatment for partial-onset seizures i...
by Lee Han-soo  |  2019-11-22 17:03
라인
Bridge Biotherapeutics aims to become global NRDO company
Bridge Biotherapeutics revealed its goal to become Korea's top no resea...
by Lee Han-soo  |  2019-11-22 15:10
라인
‘SGLT-2 inhibitor may prevent retinopathy in type-2 diabetes’
Researchers at Ajou University Hospital said sodium-glucose cotransporter-2...
by Lee Han-soo  |  2019-11-21 15:21
라인
‘Sprycel showed longer efficacy than nilotinib for chronic myeloid leukemia’
Bristol-Myers Squibb (BMS) has published the results of an observational st...
by Lee Han-soo  |  2019-11-21 14:26
라인
CJ HealthCare to export gastric acid blocker to Thailand
CJ HealthCare said Thursday that it planned to export K-Cab (Ingredient: te...
by Lee Han-soo  |  2019-11-21 10:54
라인
‘Japan much advanced than Korea in ALK-positive NSCLC treatment’
Japan moved fast to authorize to use lorlatinib, a third-generation targete...
by Kim Yun-mi  |  2019-11-20 16:16
라인
Remed aims to expand global presence through IPO
Remed expressed its aspiration to become a global leader in the newly emerg...
by Lee Han-soo  |  2019-11-20 15:30
라인
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab
PharmAbcine, a developer of antibody drugs, said it has registered the firs...
by Jeong Sae-im  |  2019-11-19 17:18
라인
‘Udenafil improved exercise in single ventricle heart disease’
Mezzion Pharma said its investigational drug udenafil improved exercise cap...
by Jeong Sae-im  |  2019-11-18 14:48
라인
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment”
Given the licensing and insurance system in Korea, the Xalkori-Alecensa seq...
by Kim Yun-mi  |  2019-11-15 17:48
라인
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health and Welfare revoked Kolon Life Science’s innovative ...
by Lee Han-soo  |  2019-11-15 17:26
여백
여백
여백
Back to Top